Evotec SE (EVO) stock
EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF
$1.46−0.02 (-1.35%)
Close on Nov 18, 2026Market cap $519.11MP/E –Yield –
Evotec net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2022 it was -€175.66M, down 181.5% from the year before.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -€175.66M | -181.5% |
| FY2021 | Dec 31, 2021 | €215.51M | +3332.8% |
| FY2020 | Dec 31, 2020 | €6.28M | -83.5% |
| FY2019 | Dec 31, 2019 | €38.16M | – |
See a number that looks wrong?